Aethlon Medical (NSDQ:AEMD) subsidiary Exosome Sciences said today it is launching a study of a biomarker candidate intended to detect and monitor chronic traumatic encephalopathy in a sample of retired NFL players. Screening is expected to begin in the coming weeks, Exosome Sciences said, and looks to enroll former NFL players at high risk of suffering from […]
Tracking the neurodegenerative disease haunting American football
Aethlon Medical (NSDQ:AEMD) subsidiary Exosome Sciences said today that it plans to support a clinical trial involving retired NFL players to study a biomarker-based diagnostic to detect and monitor chronic traumatic encephalopathy in living people. CTE, a neurodegenerative disease found in American football players and people with a history of repetitive trauma to the head, […]
Study finds biomarkers linked to NFL players’ brain injuries
